Диссертация (1174217), страница 32
Текст из файла (страница 32)
/ T. Muka, C. OliverWilliams, S. Kunutsor, [et al.] // JAMA Cardiol. – 2016. – Vol. 1. – N 7. –P. 767-776.263. Muka, T. Estrogen receptor β actions in the female cardiovascular system: Asystematic review of animal and human studies. / T. Muka, K.G. Vargas, L. Jaspers// Maturitas. – 2016.
– Vol. 86. – P. 28-43.264. Muroi, Y. A novel neuropeptide Y neuronal pathway linking energy state andreproductive behavior. / Y. Muroi, T. Ishii // Neuropeptides. – 2016. – Vol. 59. –P. 1-8.194265. Nastri, C.O. Hormone therapy for sexual function in perimenopausal andpostmenopausal women. / C.O. Nastri, L.A. Lara, R.A. Ferriani, [et al.] // CochraneDatabase Syst Rev. – 2013. – Vol. (6). – CD009672.266.
Nestor, C.C. Cross-talk between reproduction and energy homeostasis: centralimpact of estrogens, leptin and kisspeptin signaling. / C.C. Nestor, M.J. Kelly, O.K.Rønnekleiv // Horm Mol Biol Clin Investig. – 2014. – Vol. 17. – N. 3. – P.
109-128.267. Nilsson, O. Endocrine regulation of the growth plate. / O. Nilsson, R. Marino, F. DeLuca, [et al.] // Horm Res. – 2005. – Vol. 64. – N. 4. – P. 157-165.268. O'Donnell, E. Impaired vascular function in physically active premenopausalwomen with functional hypothalamic amenorrhea is associated with low shear stressand increased vascular tone.
/ E. O'Donnell, J.M. Goodman, S. Mak, P.J. Harvey. //J Clin Endocrinol Metab. – 2014. – Vol. 99. – N. 5. – P. 1798- 806.269. Olson, M.B. Symptoms, myocardial ischaemia and quality of life in women: resultsfrom the NHLBI-sponsored WISE Study. / M.B. Olson, S.F. Kelsey, K. Matthews,[et al.].
// Eur Heart J. – 2003. – Vol. 24. – N. 16. – P. 1506-14.270. Orita, M. Detection of polymorphisms of human DNA by gel electrophoresis assingle-strand conformation polymorphisms. / M. Orita, H. Iwahana, H. Kanazawa,[et al.] // Proc Natl Acad Sci USA. – 1989. – Vol. 86. – N. 8. – P. 2766-2770.271. Ofosu, W.A. The role of oestrogen receptor beta (ERβ) in the aetiology andtreatment of type 2 diabetes mellitus.
/ W.A. Ofosu, D. Mohamed, O. Corcoran,O.O. Ojo/// Curr Diabetes Rev. – 2018. – Vol. 14. – P. 345-351.272. Palacios, S. Progestogen safety and tolerance in hormonal replacement therapy./ S.Palacios, A. Mejía.// Expert Opin Drug Saf. – 2016. – Vol. 15. – N. 11. –P. 1515-1525.273. Pandaranandaka, J. Differential effects of exogenous and endogenous estrogen onanxiety as measured by elevated T-maze in relation to the serotonergic system / J.Pandaranandaka, S. Poonyachoti, S. Kalandakanond-Thongsong // Behav BrainRes. – 2009.
– Vol. 198. – N. 1. – P. 142-148.274. Park H.K. Physiology of leptin: energy homeostasis, neuroendocrine function andmetabolism / H.K. Park, R.S. Ahima // Metabolism. – 2015. – Vol. 64. – N. 1. –P. 24-34.195275. Paterni, I. Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligandsand clinical potential / I. Paterni, C. Granchi, J.A. Katzenellenbogen, F. Minutolo //Steroids. – 2014. – Vol. 90.
– P. 13-29.276. Pekic, S. Diagnosis of endocrine disease: Expanding the cause of hypopituitarism./ S. Pekic, V. Popovic // Eur J Endocrinol. – 2017. – Vol. 176. – N. 6. –P. R269-R282.277. Pelusi, C. Endocrine dysfunction in hereditary hemochromatosis.
/ C. Pelusi, D.I.Gasparini, N. Bianchi, R. Pasquali // J Endocrinol Invest. – 2016. – Vol. 39. – N. 8.– P. 837-847.278. Pentz, I. Functional hypothalamic amenorrhea and its psychological correlates: acontrolled comparison. / I. Pentz, S. Nakić Radoš // J Reprod Infant Psychol. – 2017.– Vol. 35. – N. 2. – P.
137-149.279. Pereira, A.M. Treatment of nonfunctioning pituitary adenomas: what were thecontributions of the last 10 years? A critical view. / A.M. Pereira, N.R. Biermasz //Ann Endocrinol (Paris). – 2012. – Vol. 73. – N. 2. – P. 111-116.280. Peri, A. Neuroprotective effects of estrogens: the role of cholesterol. / A. Peri // JEndocrinol Invest. – 2016. – Vol.
39. – N. 1. – P. 11-18.281. Pines, A. Alzheimer's disease, menopause and the impact of the estrogenicenvironment. / A. Pines // Climacteric. – 2016. – Vol. 19. – N. 5. – P. 430-432.282. Pinto, M. Mechanisms linking mtDNA damage and aging / M. Pinto, C.T.
Moraes// Free Radic Biol Med. – 2015. – Vol. 85. – P. 250-258.283. Pitkin, J. Continuous combined hormone replacement therapy relieves climactericsymptoms and improves health-related quality of life in early postmenopausalwomen. / J. Pitkin, V.P. Smetnik, P. Vadász, [et al.]; Indivina 321 Study Group //Menopause Int. – 2007. – Vol. 13. – N. 3. – P. 116-123.284.
Plant, M.T. The hypothalamo-pituitary-gonadal axis. / M.T. Plant // J Endocrinol. –2015. – Vol. 226. – N. 2. – P. T41-T54.285. Polotsky, H.N. Metabolic implications of menopause. / H.N. Polotsky, A.J.Polotsky // Semin Reprod Med. – 2010. – Vol. 28. – N5. – P. 426-434.196286. Prokai, D. Neuroprotection via Reduction in Stress: Altered Menstrual Patterns asa Marker for Stress and Implications for Long-Term Neurologic Health in Women./ D. Prokai, S.L. Berga // Int J Mol Sci. – 2016. – Vol. 17.
– N. 12. – pii: E2147.287. Quaynor, S.D. Targeted next generation sequencing approach identifies eighteennew candidate genes in normosmic hypogonadotropic hypogonadism and Kallmannsyndrome. / S.D. Quaynor, M.E. Bosley, C.G. Duckworth, [et al.] // Mol CellEndocrinol. – 2016. – Vol. 437. – P. 86-96.288. Raftogianni, A. Deciphering the Contributions of CRH Receptors in the Brain andPituitary to Stress-Induced Inhibition of the Reproductive Axis. / A.Raftogianni, L.C. Roth, D.
García-González // Front Mol Neurosci. – 2018. –Vol. 11. – P. 305.289. Rech, CM. Low testosterone levels are associated with endothelial dysfunction inoophorectomized early postmenopausal women. / C.M. Rech, R. Clapauch, Md. deSouza, E.
Bouskela // Eur J Endocrinol. – 2016. – Vol.174. – N. 3. – P. 297-306.290. Reddy Kilim, S. A comparative study of lipid profile and oestradiol in pre- and postmenopausal women. / S. Reddy Kilim, S.R.Chandala // J Clin Diagn Res. – 2013. Vol. 7. – N. 8. – P. 1596-1598.291. Rees, M. EMAS position statements and clinical guides. / M. Rees // Maturitas. –2014. – Vol.
77. – N. 4. – P. 303-304.292. Rendina, D.N. Precipitous Dehydroepiandrosterone Declines Reflect DecreasedPhysical Vitality and Function. / D.N. Rendina, C.D. Ryff, C.L.Coe. // J GerontolA Biol Sci Med Sci. – 2017. – Vol. 72. – N. 6. – P. 747-753.293. Reslan, O.M. Vascular effects of estrogenic menopausal hormone therapy. / O.M.Reslan, R.A. Khalil // Rev Recent Clin Trials. – 2012. – Vol. 7.
– N. 1. – P. 47–70.294. Rettberg, J.R. Estrogen: a master regulator of bioenergetic systems in the brain andbody. / J.R. Rettberg, J. Yao, R.D. Brinton // Front Neuroendocrinol. – 2014. –Vol. 35. – N. 1. – P. 8-30.295. Roberts, H. Managing the menopause: An update. / H. Roberts, M. Hickey //Maturitas. – 2016. – Vol. 86. – P. 53-58.197296. Robin, G. Polycystic Ovary-Like Abnormalities (PCO-L) in women with functionalhypothalamic amenorrhea. / G. Robin, C. Gallo, S. Catteau-Jonard, [et al.].// J ClinEndocrinol Metab. – 2012. – Vol. 97.
– N. 11. – P. 4236–43.297. Rocca, W.A. Oophorectomy, estrogen, and dementia: a 2014 update / W.A. Rocca,B.R. Grossardt, L.T. Shuster // Mol Cell Endocrinol. – 2014. – Vol. 389. – N. 1-2.– P. 7-12.298. Rossmanith, W.G. Pituitary gonadotropin responsiveness to repeated gonadotropinreleasing hormone (GnRH) stimulations in patients with chronic anovulation. /W.G. Rossmanith, S. Schramm, R.
Benz, C. Lauritzen // Gynecol Endocrinol. –1991. – Vol. 5. – P. 185-196.299. Rudolph, L.M. Actions of Steroids: New Neurotransmitters. / L.M. Rudolph, C.A.Cornil, M.A. Mittelman-Smith, [et al.] // J Neurosci. – 2016. – Vol. 36 (45). –P. 11449-11458.300. Salpeter, S.R. Meta-analysis: effect of hormone-replacement therapy oncomponents of the metabolic syndrome in postmenopausal women. / S.R. Salpeter,J.M.
Walsh, T.M. Ormiston, [et al.] // Diabetes Obes Metab. – 2006. – Vol. 8. –N. 5. – P. 538-554.301. Santoro, N. Reproductive Hormones and the Menopause Transition. / N.Santoro, E.S. Taylor // Obstet Gynecol Clin North Am. – 2011. – Vol. 38. – N. 3.– P. 455-466.302.